Rosenbaum Jay D. Bristol Myers Squibb CO Transaction History

Rosenbaum Jay D.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $13,379 - $14,855	-210 Reduced 2.65%	7,721 $493,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $129,448 - $146,824	1,970 Added 33.05%	7,931 $549,000
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $39,786 - $47,113	581 Added 10.8%	5,961 $428,000
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $188 - $111,648	1,453 Added 37.0%	5,380 $382,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $285,178 - $314,081	3,927 New	3,927 $302,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rosenbaum Jay D., based on Form 13F filings with the SEC.

Stay updated on Rosenbaum Jay D. with notifications on news.